IMR Press / FBL / Volume 22 / Issue 1 / DOI: 10.2741/4473

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Review

Gene therapy using bacterial vectors

Show Less
1 Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
2 Institute for Clinical and Translational Medicine, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia
3 Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
4 Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia
Academic Editor:Munis Dundar
Front. Biosci. (Landmark Ed) 2017, 22(1), 81–95;
Published: 1 January 2017
(This article belongs to the Special Issue Genes and genetics)

Bacteria can be used for gene therapy via two strategies – either by transfection of eukaryotic host cells using bacteria – bactofection or by alternative gene therapy that does not alter the host genome, but uses the prokaryotic expression system that can be controlled or stopped from outside. While bactofection is optimal for gene substitution and DNA vaccination, alternative gene therapy is suitable for in situ delivery of proteins and treatment with intracellular bactochondria. A specific form of bacteria-mediated gene therapy is the transkingdom RNA interference. In this review advantages and issues related to bacterial vectors as well as the major applications in biomedical research are summarized. Despite numerous published experiments, especially in the treatment of solid tumors and gut infections, the progress in the clinics lags behind and major improvements in the safety and even more in the efficiency of these approaches are needed.

Alternative Gene Therapy
Transgene Expression
DNA vaccination
Back to top